JERVINE

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C27H39NO3
Molecular Weight	425.6035
Optical Activity	UNSPECIFIED
Defined Stereocenters	10 / 10
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

[H][C@@]12C[C@H](C)CN[C@@]1([H])[C@@H](C)[C@@]3(CC[C@]4([H])C(C(=O)[C@@]5([H])[C@@]4([H])CC=C6C[C@@H](O)CC[C@]56C)=C3C)O2

InChI

InChIKey=CLEXYFLHGFJONT-DNMILWOZSA-N

InChI=1S/C27H39NO3/c1-14-11-21-24(28-13-14)16(3)27(31-21)10-8-19-20-6-5-17-12-18(29)7-9-26(17,4)23(20)25(30)22(19)15(27)2/h5,14,16,18-21,23-24,28-29H,6-13H2,1-4H3/t14-,16+,18-,19-,20-,21+,23+,24-,26-,27-/m0/s1

HIDE SMILES / InChI

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/15137822
Curator's Comment: description was created based on several sources, including: https://en.wikipedia.org/wiki/Jervine | https://www.google.com/patents/US20150259313

Jervine (11-Ketocyclopamine) is a naturally occuring steroidal alkaloid is derived from the Veratrum plant species. Jervine is a teratogen implicated in birth defects when consumed by animals during a certain period of their gestation. Over the Hedgehog signaling pathway Jervine effectively inhibit the tumor growth using three human tumor xenograft models including lung cancer, pancreatic cancer and basal cell carcinoma. Jervine has the potential to advance to a treatment for different tumors.

Originator

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
Hedgehog signaling pathway 11 Target ID: map04340 Sources: https://www.ncbi.nlm.nih.gov/pubmed/12606278	Inhibitor 8297		50.0 nM [IC50]

Conditions

Condition	Modality	Targets	Highest Phase	Product
Cancer 592 Sources: https://www.ncbi.nlm.nih.gov/pubmed/20013819 https://www.ncbi.nlm.nih.gov/pubmed/15137822	Primary		Preclinical	Unknown Approved Use Unknown

PubMed

Title	Date	PubMed
Critical time window of hedgehog-dependent angiogenesis in murine yolk sac.	2006 Mar	16414085
Synthesis of all diastereomers of the piperidine--alkaloid substructure of cyclopamine.	2009 Dec 3	19883099
Hedgehog signaling is required at multiple stages of zebrafish tooth development.	2010 Nov 30	21118524

Patents

Sample Use Guides

In Vivo Use Guide

Oral: 40 or 60 or 80 mg/kg once every day (during 21 days). Intravenous: 20 or 40 or 80 mg/kg once every day (during 21 days).

Route of Administration: Other

In Vitro Use Guide

Tongues treated with jervine at 10 μM exhibited a dorsal anterior tongue that was almost completely occupied by fungiform papillae.

Name

Type

Language

JERVINE

Common Name

English

JERVINE [HSDB]

Common Name

English

NSC-23898

Code

English

NSC-7520

Code

English

VERATRAMAN-11-ONE, 17,23-EPOXY-3-HYDROXY-, (3.BETA.,23.BETA.)-

Common Name

English

SPIRO(9H-BENZO(A)FLUORENE-9,2'(3'H)-FURO(3,2-B)PYRIDIN)-11(1H)-ONE, 2,3,3'A,4,4',5',6,6',6A,6B,7,7',7'A,8,11A,11B-HEXADECAHYDRO-3-HYDROXY-3',6',10,11B-TETRAMETHYL-, (2'R,3S,3'R,3'AS,6'S,6AS,6BS,7'AR,11AS,11BR)-

Systematic Name

English

JERVIN

Common Name

English

JERVINE [MI]

Common Name

English

Code System Code Type Description

PUBCHEM

10098